Fig. 1 · Structure
Documents & Downloads
β-Nicotinamide mononucleotide, reduced form disodium
NAD+ Precursor
β-Nicotinamide mononucleotide, reduced form disodium serves as a precursor to NAD+, playing a crucial role in cellular energy metabolism. This compound significantly elevates NAD+ and NADH levels while inhibiting glycolysis, the tricarboxylic acid cycle, and cellular proliferation. Its biological effects are mediated through the enzyme nicotinamide mononucleotide adenylyltransferase (NMNAT), making it a valuable reagent for research in metabolic pathways and potential therapeutic applications targeting NAD+ metabolism.
In Stock
Free Aliquoting for Your Order
Tell us your preferred amount per vial. We’ll confirm the options.
Specifications
| Manufacturer | Adooq Bioscience |
|---|---|
| CAS Number | 108347-85-9 |
| Applications | NAD+ Precursor |
| Formula | C11H15N2Na2O8P |
| Molecular Weight | 380.20 |
| Synonyms | NMNH disodium |
| SMILES | O[C@H]1[C@@H](O)[C@H](N2C=C(CC=C2)C(N)=O)O[C@@H]1COP(O[Na])(O[Na])=O |
Storage & Solubility
In Vitro Solubility
Reported Solubility
No reported solubility data are available for this product.
Preparing Stock Solutions
| Concentration | |
|---|---|
Values use four significant digits. Prepare to the final solution volume; this is not the volume of solvent to add.
Stock preparation is unavailable for this product molecular weight.
Calculated stock concentrations do not establish solvent solubility. Refer to the reported solubility data for experimental guidance.
Storage
Store powder at -20°C, keep desiccated.
In powder form, the chemical is stable for 36 months.
In solution, store at -20°C and use within 1 month to prevent loss of potency. Aliquot to avoid multiple freeze/thaw cycles.